A de novo pathogenic variant in DHX30 gene in a fetus with isolated dysgenesis of the corpus callosum.
Karina Krajden HaratzGustavo MalingerUri ErlikRayna GoldsteinMordechai ShohatBirnbaum RoeePublished in: Prenatal diagnosis (2024)
A 36 years old woman in her first pregnancy was referred at 24w3d for a dedicated neurosonographic examination due to a suspected short corpus callosum (CC). The examination depicted a dysgenetic CC with asymmetric thickness at the level of the body in coronal views, very thin in the midline and thicker in both sides, suggesting bilateral formation of Probst bundles. The BPD, HC, and transverse cerebellar diameters were in the normal low range without associated growth restriction. Associated anomalies were not detected in the brain or other organs. Following genetic consultation and a normal CMA, trio exome sequencing was performed and a de novo missense pathogenic mutation c.2353 C > T in the DHX30 gene was detected. This variant has been previously reported in children and adults, mostly with a severe phenotype including neurodevelopmental disorder with variable motor and language impairment, but also mild phenotypes have been reported. MRI describes delayed myelination, ventriculomegaly, and cortical and cerebellar atrophy as imaging features in affected patients. This is the first prenatal report of a DHX30-associated neurodevelopmental disorder in which the fetus presents with isolated callosal dysgenesis, stressing the importance of exome sequencing in fetuses with this condition, as far as it is phenotypic presentation of numerous syndromes with different outcomes.
Keyphrases
- pulmonary embolism
- copy number
- genome wide
- end stage renal disease
- case report
- single cell
- ejection fraction
- chronic kidney disease
- newly diagnosed
- high resolution
- peritoneal dialysis
- magnetic resonance imaging
- young adults
- palliative care
- autism spectrum disorder
- prognostic factors
- dna methylation
- preterm birth
- genome wide identification
- early onset
- white matter
- gene expression
- metabolic syndrome
- intellectual disability
- magnetic resonance
- insulin resistance
- resting state
- pregnancy outcomes
- transcription factor
- blood brain barrier
- genome wide analysis